Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients

Abroad (travel likely)Recruiting

Conditions

Obesity · Hyperlipidemias · Polycystic Ovary Syndrome · Hypertension · Coronary Heart Disease · Heart Failure · Depression, Anxiety · Type II Diabetes · Metabolic Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

West Virginia School of Osteopathic Medicine, Lewisburg, West Virginia, United States
Contact: Study coordinator (Dovenia Ponnoth, Ph.D.) · dponnoth@osteo.wvsom.edu · 3046476297
Contact: Study coordinator (Peter Feltman) · pfeltman@osteo.wvsom.edu · 3046476284

Study leads

Christopher L Pankey, Ph.D.
Principal Investigator
West Virginia School of Osteopathic Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

Prostate Cancer · Metabolic Syndrome · Obesity

Abroad (travel likely)RecruitingEARLY_PHASE1

London, Canada

Smartwatch-based Intervention for Cardiovascular Health (SWITCH)

Prehypertension · Borderline Dyslipidemia · Overweight , Obesity

Abroad (travel likely)Recruiting

Beijing, China · Cangzhou, China

Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)

Obesity

Abroad (travel likely)RecruitingPHASE1

Cypress, United States

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Obesity · Overweight · Diabetes Mellitus, Type 2

Abroad (travel likely)RecruitingPHASE2

Gilbert, United States · Phoenix, United States